Reuters
24 Sept 2026, 09:18 UTC · 1h ago
Verdict
Headline takes no side. We score GRFS −0.20 across one claim — slightly bearish.
−0.20slightly bearish
More negative than 66% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
Grifols stated that the suspension of its plasma collection license at the Taylor Avenue facility in Winnipeg by Health Canada has no impact on operations.
Newpublished 2026-09-24
So whatSince operations are unaffected, no downward revision to quarterly plasma volume guidance is expected.
More negative than 66% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 66% of ticker scores this week
The company's license to collect plasma at a Canadian facility was suspended, despite claims of no operational impact.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
4h ago
—
GRFS hasn't traded since this ran. Last close $7.20 (Sep 23); the reaction starts at the next open.
GRFS chart →
